DORIS ALVAREZ: Open Payments
NPI 1407272818 · SUNCITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 22 payments from 9 companies in 2025. Trend: 2023 $896 · 2024 $1,012 · 2025 $1,839
Food & beverage: $1,740Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $603 |
| ABBVIE INC. | 5 | $501 |
| Regeneron Pharmaceuticals, Inc. | 1 | $127 |
| QOL Medical, LLC | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $109 |
| Madrigal Pharmaceuticals | 1 | $107 |
| Merit Medical Systems Inc | 1 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $104 |
| Lilly USA, LLC | 1 | $63 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Sucraid, RINVOQ, MAVYRET, REZDIFFRA, ESOPHYX.
Industry payments across AZ — which companies pay providers there.
